Gunnar Kristensen

9PUBLICATIONS
59CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 12, 2026
Applicability of mitotic figure counting by deep learning: a development and pan-cancer validation study.

Joakim Kalsnes, Maria X Isaksen, Frida Julbø

|Aug 15, 2023
Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer.

Rachel N Grisham, Ignace Vergote, Susana Banerjee

|Mar 29, 2023
CA-125 Early Dynamics to Predict Overall Survival in Women with Newly Diagnosed Advanced Ovarian Cancer Based on Meta-Analysis Data.

Eleni Karamouza, Rosalind M Glasspool, Caroline Kelly

|Nov 04, 2022
Optimal Treatment Duration of Bevacizumab as Front-Line Therapy for Advanced Ovarian Cancer: AGO-OVAR 17 BOOST/GINECO OV118/ENGOT Ov-15 Open-Label Randomized Phase III Trial.

Jacobus Pfisterer, Florence Joly, Gunnar Kristensen

|Nov 27, 2021
Risk Stratification of Endometrial Cancer Patients: FIGO Stage, Biomarkers and Molecular Classification.

Jenneke C Kasius, Johanna M A Pijnenborg, Kristina Lindemann

|Apr 03, 2021
Salvage Radiation for Pelvic Relapse after Surgically Treated Endometrial Cancer.

Kristina Lindemann, Elisabeth Smogeli, Milada Cvancarova Småstuen

Pageof 2

Frequent Collaborators

2 joint publications

Andreas Kleppe

2 joint publications

Jone Trovik

2 joint publications

Felix Hilpert

2 joint publications

Henrica M J Werner